Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “POTASSIUM PERMANGANATE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Effect of Mg2+ on kinetics of oxidation of pyrimidines in duplex DNA by potassium permanganate.

Potassium permanganate oxidation of pyrimidine bases is often used to probe single-stranded regions in functional DNA-protein complexes. However, so far reactivity of these bases in double-stranded DNA has not been studied quantitatively. We have investigated the kinetics of oxidation of pyrimidines in supercoiled pDS3 plasmid dsDNA by quantitative KMnO4 footprinting, in connection with parallel studies on the effect of Mg2+ on kinetics of oxidation of individual thymines in the single-stranded region of the open transcription complex of Escherichia coli RNA polymerase at a cognate Pa promoter contained in this plasmid. Rate constants of oxidation for pyrimidines, kj, in selected regions of pDS3 DNA, including Pa promoter, were determined under single-hit reaction conditions in the absence and presence of 10 mM MgCl2. Their values appeared to be sequence-dependent and were: (i) the largest for Ts in 5'TA3' and 5'TC3' steps, while 2-4 times smaller for 5'-adjacent ones in TT(A,G,C) and TTT(A) runs, (ii) for Cs in 5'TC3' steps 2-4 fold smaller than for adjacent Ts, and (iii) in the presence of Mg2+ generally larger by a sequence-dependent factor: in 5'TC3' steps of about 2 and 4 for Ts and Cs, respectively, in 5'TA3' steps of TTA and TTTA sequences for 3'-terminal Ts of about 3, while for their 5'-neighbors o tinctly smaller value of about 2. Comparison of kj data for corresponding Ts located between +1 and -10 regions of Pa promoter in dsDNA and in ssDNA form in the open transcription complex, reported elsewhere, demonstrates that reactivity of pyrimidines in dsDNA is by 2-3 orders of magnitude smaller. The effect of Mg2+ in dsDNA is interpreted in terms of electrostatic barrier to diffusion of MnO4- on DNA surface, which is lowered by diffusive binding of these ions to backbone phosphates, involving also sequence-specific contacts with bases in the minor and major grooves of B-DNA.

DNA Footprinting↗

Fatal acute hepatorenal failure following potassium permanganate ingestion.

Potassium permanganate (KMnO4), a powerful oxidizing agent, is readily available without prescription. Tissue contact produces coagulation necrosis and the lethal consequences of oral ingestion are well described, with most deaths because of airway oedema and obstruction or circulatory collapse. Whilst systemic toxicity is reported, its mechanism is unclear. We describe a case of suicidal ingestion of KMnO4 followed by acute hepatorenal toxicity resulting in the death of the patient. The clinical course bore close resemblance to that of severe paracetamol overdose. We discuss the pathogenesis of the systemic toxicity of KMnO4 and postulate that it is due to oxidative injury from free radicals generated by the absorbed permanganate ion. We recommend that N-acetyl cysteine be given within the first few hours to all patients with potassium permanganate poisoning.

Accidents, Home↗

The management of terminal carcinoma with oral potassium permanganate.

Oral potassium permanganate has been used in the management of terminal carcinoma in three patients. Symptomatic improvement occurred in all three, with elimination of oral foetor in one patient and diminished requirement of analgesics in the other two. The mental state of each patient was improved and normal activities were resumed.

Aged↗

Haemorrhagic pancreatitis--a cause of death in severe potassium permanganate poisoning.

Severe potassium permanganate poisoning (more than 10 g of potassium permanganate) is invariably associated with massive systemic upset and death. Multiple organ damage has been recognized as an inevitable consequence of such an overdose, although pancreatitis has not been previously reported. Death due to cardiovascular collapse and profound hypotension is a common end point in those who reach hospital, but the pathogenesis is uncertain. We report a case of haemorrhagic pancreatitis following an overdose of potassium permanganate and suggest that this complication may be an unrecognized factor contributing to the extremely high mortality rate associated with this condition.

Acute Disease↗

Genotoxic activity of potassium permanganate in acidic solutions.

Potassium permanganate (KMnO4) combined with sulfuric acid is a strongly oxidizing mixture which has been recommended for the destruction and the decontamination of various mutagens/carcinogens in the publication series of the International Agency for Research on Cancer. Evaluation of the genotoxicity of 4 potassium permanganate solutions was performed using a microtechnique of the Ames test with the tester strains TA97, TA98, TA100 and TA102 with and without metabolic activation. Presence of direct-acting mutagens was detected in all the samples with the tester strain TA102 without S9 mix (163-357 revertants/microliters of the solutions). Three samples containing either acetone or ethanol as an organic solvent also induced a mutagenic response on tester strain TA100 without S9 mix (167-337 revertants/microliters). In addition, DNA damage in human peripheral blood lymphocytes was also measured for one of the mixtures by a new technique: the single-cell gel assay (SCGA). A sample with no organic solvent induced DNA damage in human lymphocytes with a dose-response relationship as determined by SCGA. The major mutagenic agent generated by the permanganate solutions was found to be manganese ion (Mn2+). Both manganese sulfate (MnSO4) and manganese chloride (MnCl2) gave mutagenic dose-response relationships on tester strain TA102 without S9 mix. The mutagenic potencies were 2.8 and 2.4 revertant/nmole for MnSO4 and MnCl2 respectively. MnCl2 also induced DNA damage in human lymphocytes as determined by the SCGA. The genotoxic effects of KMnO4 in acidic conditions were probably mediated by the conversion of MnO4- to Mn2+. KMnO4 in alkaline solutions did not produce mutagenic species and may offer an alternative for the degradation of genotoxic compounds.

Biotransformation↗

Decolorization of dyes and textile wastewater by potassium permanganate.

Decolorization of 10 types of dye solutions by potassium permanganate was studied. Effects of reaction conditions on the decolorization efficiency were examined in batch experiments. The pH value had a significant effect on the decolorization efficiency. When pH value <1.5, the decolorization efficiency was very high. When pH value >4.0, the dye solutions were almost not decolorized. Concentration of potassium permanganate and temperature also showed significant effects on the decolorization efficiency. The decolorization rate of dye solutions by potassium permanganate was rapid, and most of dye solutions can be decolorized effectively. The results of total organic carbon indicated that dye solutions were degraded incompletely by potassium permanganate. The results of treatment of textile wastewater by potassium permanganate indicated that the oxidation with potassium permanganate might be used as a pre-treatment process before biological treatment.

Color↗

Chemiluminescence accompanied by the reaction of gold nanoparticles with potassium permanganate.

It was found that potassium permanganate (KMnO(4)) could react with gold nanoparticles in a strong acid medium to generate particle size-dependent chemiluminescence (CL). For gold nanoparticles with the size of 2.6 or 6.0 nm, the reaction was fast and could produce the excited state Mn(II) with light emission around 640 nm. For gold nanoparticles larger than 6.0 nm, no light emission was observed due to a much slower reaction rate. The CL intensity was found to increase linearly with the concentration of 2.6 nm gold nanoparticles. The effects of the acid medium, concentration of KMnO(4) and presence of N(2) and O(2) were investigated. UV-Vis absorption spectra and X-ray photoelectron spectra (XPS) measured before and after the CL reaction were analyzed. A CL mechanism has been proposed suggesting that the potassium permanganate was reduced by gold nanoparticles in the strong acid medium to the excited state Mn(II), yielding light emission. The results bestow new light on the size-dependent chemical reactivities of the gold nanoparticles and on nanoparticle-induced chemiluminescence. The CL reaction was considered to be of potential use for bioanalysis applications.

Biosensing Techniques↗

Comparative acute toxicity of potassium permanganate to nontarget aquatic organisms.

Potassium permanganate (KMnO4) is used worldwide in freshwater pond aquaculture for treatment and prevention of waterborne external parasitic, bacterial, and fungal diseases. Nevertheless, KMnO4 has not been approved by the U.S. Food and Drug Administration, and insufficient information exists to allow evaluation of the environmental risk of KMnO4 exposures. Limited data exist concerning KMnO4 toxicity to nontarget species in systems receiving aquaculture effluent from treated ponds. The goal of this research is to generate effects data for use in developing an ecological risk assessment of KMnO4. Toxicity tests were used to compare the relative sensitivities of five standard aquatic test species to KMnO4. Acute toxicity test results using synthetic moderately hard water show static 96-h mean median lethal concentration (LC50) values +/- standard deviation (SD) of 0.058 +/- 0.006 mg/L for Ceriodaphnia dubia, 0.053 +/- 0.009 mg/L for Daphnia magna, 2.13 +/- 0.07 mg/L for Pimephales promelas, 4.74 +/- 1.05 mg/L for Hyalella azteca, and 4.43 +/- 0.79 mg/L for Chironomus tentans. Most of these values are below the recommended KMnO4 treatment rate of at least 2.0 mg/L or 2.5 times the water's potassium permanganate demand (PPD; an estimation of the available reducing agents in the exposure water), suggesting significant environmental risk. However, repeating these laboratory tests using pond water resulted in significantly reduced toxicity, with static 96-h mean LC50 values (+/-SD) of 2.39 +/- 0.36 mg/L for C. dubia, 1.98 +/- 0.12 mg/L for D. magna, 11.22 +/- 1.07 mg/L for P. promelas, 13.55 +/- 2.24 mg/L for H. azteca, and 12.30 +/- 2.83 mg/L for C. tentans. The PPD of synthetic moderately hard water was 0.329 +/- 0.114 mg/L; however, pond water PPD was 5.357 +/- 0.967 mg/L. The effective disease-treating dose based on 2.5 times the PPD would thus be 0.823 and 13.392 mg KMnO4/L, respectively, exceeding the LC50 for most of these nontarget organisms, even in pond water, immediately after treatment.

Amphipoda↗

[Effects of potassium permanganate on natural organic matter chlorination activity].

Effects of potassium permanganate (PP) oxidation on natural organic matter(NOM) chlorination activity was studied in the article. Natural organic matter was separated into humic acid (HA), fulvic acid(FA), hydrophilic acid(HPIA) and non-hydrophilic acid (HPI-NA) fraction four fractions by XAD resin adsorption technique. Potassium permanganate oxidation alone increased HA and HPIA chlorination activity and decrease that of FA and HPI-NA. The chlorination activity of HA and HPIA were increased by 39.3% and 13.8% by 0.75 mg/L. potassium permanganate, but the chlorination activity of FA and HPI-NA were decreased by 33.6% and 46.9%. SUVA results showed that potassium permanganate increase FA and HPIA unsaturated band contents, and decreased that of FA and HPI-NA. Compared with coagulation, potassium permanganate combined with coagulation can decrease the trihalomethanes of HA, FA, HPIA and HPI-NA by 9.1,15.7,7.2 and 14.7 per cent compared with that of coagulation alone.

Chlorine Compounds↗

[Potassium permanganate poisoning in infancy].

Potassium permanganate intoxication in 3 infant girls (2.5, 2.5 and 5 months old, respectively) is described. In 2 the toxic solution was mistaken for a vitamin A+D preparation due to package similarity. The main clinical symptoms included restlessness, low grade fever and inflamed oral mucosa with black-brown discoloration. There was leukocytosis with a shift to the left. Complications described by others, such as hepatic and renal damage, upper air-way obstruction, gastrointestinal ulceration, bleeding tendency, methemoglobinemia and hemolysis, were not seen in our infants. Management included hemodynamic and respiratory monitoring, oral and gastric water lavage and milk ingestion. Laboratory follow-up included CBC and hepatic and renal function tests. There were no complications, and follow-up revealed no residual abnormalities.

Animals↗

Should potassium permanganate be used in wound care?

Potassium permanganate is a mild antiseptic with astringent properties. It is used in dermatology to treat weeping skin conditions. Potassium permanganate tablets are commonly used in clinical practice. The 400 mg (1:1,000) tablets are diluted in four litres of water to give a dilution of 1:10,000 (0.01%) (British Medical Association and Royal Pharmaceutical Society of Great Britain, 2003).

Administration, Topical↗

High concentration potassium permanganate eliminates protein and particle contamination of the reusable Classic laryngeal mask airway.

In this three-stage study, we test the hypothesis that supplementary cleaning with potassium permanganate > or =4 mg.l(-1) eliminates protein and particle contamination from the reusable Classic laryngeal mask airway. The first stage involved supplementary cleaning of 70 1 x 1 cm segments from deliberately contaminated laryngeal mask airways using potassium permanganate at 0, 2, 4, 8, 16, 32 and 64 mg.l(-1) and testing for protein staining. This showed that the lowest concentration required to eliminate protein contamination was 8 mg.l(-1). The second stage involved supplementary cleaning of 50 used laryngeal mask airways with either potassium permanganate 8 mg.l(-1) or saline and testing for protein staining. This showed that protein contamination was lower in the potassium permanganate group (p < 0.00001): all laryngeal mask airways in the control group and none in the potassium permanganate group were contaminated. The third stage involved scanning electron microscopic examination of 1 x 1 cm segments from three laryngeal mask airways used in the control group, three from the potassium permanganate group, plus three brand new laryngeal mask airways. The mean density of > or =1 mum surface particles was lower in the potassium permanganate 8 mg.l(-1) than the control group (21 vs. 121 .cm(-2), p < 0.0001) and was similar to brand new laryngeal mask airways (24 .cm(-2)). We conclude that supplementary cleaning with potassium permanganate 8 mg.l(-1) eliminates protein deposits from reusable laryngeal mask airways and reduces particle contamination to similar levels to brand new laryngeal mask airways.

Creutzfeldt-Jakob Syndrome↗

The mechanisms of potassium permanganate on algae removal.

The effect of potassium permanganate as preoxidant for algae-laden source water and the mechanism that it causes algae cells aggregation was investigated. Synthetic algae suspensions, prepared from lab-cultured Chodatella sp., were used for batch preoxidation and settling tests. In order to study the effect of water hardness on the function of permanganate, some algae suspensions were spiked with CaCl2 solution. Experiments with preformed MnO2 to look into its effect on algae cell aggregation were also conducted. The results show that preoxidation with potassium permanganate would promote the aggregation of algae cells, and this phenomenon was even more significant with the existence of hardness causing ion, calcium. In addition to incorporating its reducing product, MnO2, into algae floc, and increased its specific gravity, and therefore its settling velocity, permanganate may also induce the release of extracellular organic matters (EOM) from algae cell. Based on SEM observation, EOM probably enhanced the incorporation of MnO2 into algae floc. The role played by calcium ion in promoting the function of permanganate can be explained by charge neutralization and also bridging between negatively charged surfaces.

Calcium Chloride↗

The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.

Alterations in affinity of amyloid for Congo red after incubation of tissue sections with potassium permanganate, as described by Wright el al, were studied. The affinity of amyloid for Congo red after incubation with potassium permanganate did not change in patients with myeloma-associated amyloidosis, familial amyloidotic polyneuropathy, medullary carcinoma of the thyroid, pancreatic island amyloid, and cerebral amyloidosis. Affinity for Congo red was lost after incubation with potassium permanganate in tissue sections from patients with secondary amyloidosis and amyloidosis complicating familial Mediterranean fever (consisting of amyloid AA). Patients with primary amyloidosis could be divided into two groups, one with potassium-permanganate--sensitive and one with potassium-permanganate--resistant amyloid deposits. These two groups correlated with the clinical classification in typical organ distribution (presenting with nephropathy) and atypical organ distribution (presenting with cardiomyopathy, nephropathy, and glossopathy) and the expected presence of amyloid AA or amyloid AL. Potassium permanganate sensitivity seems to be restricted to amyloid AA. The potassium permanganate method can be important in dividing the major forms of generalized amyloidosis in AA amyloid and non-AA amyloid. This can be used for differentiating early stages of the disease and cases otherwise difficult to classify. It is important to define patient groups properly, especially in evaluating the effect of therapeutic measures. (Am J Pathol 97:43--58, 1979).

Amyloid↗

Potassium permanganate reduces protein contamination of reusable laryngeal mask airways.

We tested the hypothesis that supplementary cleaning with potassium permanganate 2 mg/L eliminates protein deposits from reusable laryngeal mask airways (LMAs). Sixty previously used classic LMAs were hand-washed, machine-washed, dried, autoclaved, and then randomly allocated into two groups for supplementary cleaning. In Group A, the cuff was immersed in potassium permanganate 2 mg/L at 20 degrees C for 20 min. In Group B (control), the cuff was immersed in sterile water at 20 degrees C for 20 min. After supplementary cleaning, the LMAs were immersed in a protein staining solution and rinsed, and a high-resolution digital image was taken of the dorsal surface. The severity of staining was scored by an observer blinded to the type of supplementary cleaning. The severity of protein contamination was reduced after supplementary cleaning in potassium permanganate (P < 0.00001). Protein contamination was detected on 20% of LMAs after supplementary cleaning in potassium permanganate, compared with all LMAs in the control group. We conclude that supplementary cleaning with potassium permanganate 2 mg/L does not eliminate protein deposits from all LMAs, but it does reduce the number of devices contaminated from 100% to 20%.

Coloring Agents↗

[Analysis of potassium permanganate as addictive drug "precursor"].

Potassium permanganate is used for the production of cocaine and methylcathinone. The third convention of the UN against narcotic drugs (1988) contains a list of so-called precursors, substances commonly used for the production of narcotic drugs. The control of the precursors can be a very important step to prevent the illicit production of narcotic substances. A chemical characterization of a seized product may contribute to determine the origin of the producing company and the trade channels and to prevent further illicit deliveries. 31 samples of permanganate (19 authentic and 12 seized samples) have been analyzed for 9 metallic elements. Detailed procedures for the emission spectrography and ICP-analysis are given and the range of concentrations is tabulated. It was surprising that no significant concentrations of metals like chromium, nickel or cobalt were present. Nor was the difference between the technical and analytically pure products sufficient to make a differentiation according to origin. This is probably attributable to the technical manufacture of permanganate by electrolysis. All the statistical analyses of the results performed on the available data do not allow conclusions as to the country of origin or manufacturer, as production batches of one and the same manufacturer may also show differences. Only the morphology of the product (crystals, powder or "free flowing") allows a certain characterization. Nevertheless it seems necessary to analyze all seized samples for impurities and to establish a table of "impurity profiling" in the future in order to receive more information and to find correlations in selected cases.

Austria↗

[Gastric lesions caused by potassium permanganate tablets. Measures to be taken after ingestion].

Potassium permanganate tablets are caustic and it has been suggested that they should be removed straightaway by gastrostomy, immediately after swallowing. Some operators have been impressed by the macroscopic appearance of the stomach and have carried out gastrectomy. However, the lesions were only fairly superficial on pathological examination. In the light of a new case and 21 similar cases, treated at the Fernand Widal hospital, the authors discuss other cases in the literature. They conclude: the extreme rareness of digestive perforation; the absence of toxicity of breakdown products of potassium permanganate. They propose treatment of neutralisation of the permanganate with sodium hyposulphite, gastric lavage and supervision on a surgical unit. In case of perforation, they believe that the operation should be conservative.

Adult↗